On the public citation graph
Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential
0 signed · 55 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ange.201410672openalex-snapshot
Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a
inferredcites →https://doi.org/10.1002/anie.201410672openalex-snapshot
Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a
inferredcites →https://doi.org/10.1002/cbic.200700701openalex-snapshot
Discovery of Chromone‐Based Inhibitors of the Transcription Factor STAT5
inferredcites →https://doi.org/10.1002/cmdc.201700234openalex-snapshot
Effects of Pimozide Derivatives on pSTAT5 in K562 Cells
inferredcites →https://doi.org/10.1002/emmm.201000062openalex-snapshot
Stat5 is indispensable for the maintenance of bcr/abl‐positive leukaemia
inferredcites →https://doi.org/10.1006/meth.2001.1262openalex-snapshot
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
inferredcites →https://doi.org/10.1016/j.ccr.2005.01.007openalex-snapshot
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
inferredcites →https://doi.org/10.1016/j.exphem.2009.04.002openalex-snapshot
Acute myelogenous leukemia
inferredcites →https://doi.org/10.1016/j.leukres.2003.10.007openalex-snapshot
Molecular mechanisms of resistance of leukemia to imatinib mesylate
inferredcites →https://doi.org/10.1016/j.leukres.2018.10.019openalex-snapshot
Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia
inferredcites →https://doi.org/10.1016/j.taap.2003.12.020openalex-snapshot
Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b
inferredcites →https://doi.org/10.1016/s0037-1963(03)70024-9openalex-snapshot
Cytogenetic and molecular mechanisms of resistance to imatinib
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b00369openalex-snapshot
New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias
inferredcites →https://doi.org/10.1021/jm200720nopenalex-snapshot
Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity
inferredcites →https://doi.org/10.1021/jm501004topenalex-snapshot
Potent 11β-Hydroxylase Inhibitors with Inverse Metabolic Stability in Human Plasma and Hepatic S9 Fractions To Promote Wound Healing
inferredcites →https://doi.org/10.1021/ml500165ropenalex-snapshot
Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein
inferredcites →https://doi.org/10.1038/leu.2014.89openalex-snapshot
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
inferredcites →https://doi.org/10.1038/nature03546openalex-snapshot
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
inferredcites →https://doi.org/10.1038/nature15248openalex-snapshot
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
inferredcites →https://doi.org/10.1038/nm0596-561openalex-snapshot
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
inferredcites →https://doi.org/10.1038/s41375-017-0005-9openalex-snapshot
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
inferredcites →https://doi.org/10.1038/s41375-018-0357-9openalex-snapshot
Targeting FLT3 mutations in AML: review of current knowledge and evidence
inferredcites →https://doi.org/10.1053/shem.2002.35977openalex-snapshot
Treatment of acute myeloid leukemia: State-of-the-art and future directions
inferredcites →https://doi.org/10.1089/scd.2012.0048openalex-snapshot
Granulocyte-Colony-Stimulating Factor Stimulation of Bone Marrow Mesenchymal Stromal Cells Promotes CD34+ Cell Migration Via a Matrix Metalloproteinase-2-Dependent Mechanism
inferredcites →https://doi.org/10.1097/00001622-200211000-00005openalex-snapshot
Mechanisms of resistance to imatinib mesylate in Bcr-Abl–positive leukemias
inferredcites →https://doi.org/10.1111/j.1600-0609.2012.01825.xopenalex-snapshot
Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia
inferredcites →https://doi.org/10.1126/science.1099480openalex-snapshot
Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
inferredcites →https://doi.org/10.1158/1535-7163.mct-14-0883openalex-snapshot
Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
inferredcites →https://doi.org/10.1172/jci33037openalex-snapshot
Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARγ/STAT5 signaling pathway in macaques
inferredcites →https://doi.org/10.1172/jci94509openalex-snapshot
STAT5BN642H is a driver mutation for T cell neoplasia
inferredcites →https://doi.org/10.1177/1947601912466555openalex-snapshot
The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations
inferredcites →https://doi.org/10.1182/blood-2005-10-4110openalex-snapshot
STAT5 signaling is required for the efficient induction and maintenance of CML in mice
inferredcites →https://doi.org/10.1182/blood-2009-11-255232openalex-snapshot
The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
inferredcites →https://doi.org/10.1182/blood.2020005381openalex-snapshot
Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance
inferredcites →https://doi.org/10.1182/blood.v95.6.2118openalex-snapshot
STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells
inferredcites →https://doi.org/10.1182/blood.v96.12.3907openalex-snapshot
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways
inferredcites →https://doi.org/10.1182/blood.v98.6.1752openalex-snapshot
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12…
inferredcites →https://doi.org/10.1586/14737140.2015.992420openalex-snapshot
Identifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping
inferredcites →https://doi.org/10.18632/oncotarget.2465openalex-snapshot
Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia
inferredcites →https://doi.org/10.2174/1389557043487321openalex-snapshot
Imatinib (STI571) Resistance in Chronic Myelogenous Leukemia: Molecular Basis of the Underlying Mechanisms and Potential Strategies for Treatment
inferredcites →https://doi.org/10.2741/2274openalex-snapshot
STAT5 signaling in normal and pathologic hematopoiesis
inferredcites →https://doi.org/10.3390/cancers11122043openalex-snapshot
A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells
inferredcites →https://doi.org/10.3390/cancers12010240openalex-snapshot
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4984473openalex-extracted
Synthesis and Biological Evaluation of New Inhibitors of Jak/Stat Pathway in Colorectal Cancer
inferred← citeshttps://doi.org/10.1002/ardp.70307openalex-snapshot
Emerging Indole and Azaindole Hybrid Agents for Leukemia Therapy: Recent Research Advances and Therapeutic Potential
inferred← citeshttps://doi.org/10.1002/cmdc.202501079openalex-snapshot
New Binding Sites for JAK2 Inhibition in Myeloproliferative Neoplasms: Structural Insights, Therapeutic Potential, and Future Directions
inferred← citeshttps://doi.org/10.1002/ejoc.202200962openalex-snapshot
Fast Transition Metal‐Free Synthesis of Functionalized Oxindoles and Dihydroquinoline‐2‐ones Under Microwave Irradiation
inferred← citeshttps://doi.org/10.1016/j.ejmcr.2025.100281openalex-snapshot
Key determinants of the chemo-sensitizing activity of novel Telmisartan derivatives
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.117211openalex-snapshot
Novel antileukemic compound with sub-micromolar potency against STAT5 addicted myeloid leukemia cells
inferred← citeshttps://doi.org/10.1016/j.rechem.2024.102015openalex-snapshot
Synthesis and biological evaluation of new tri-heterocyclic derivatives as anti-colorectal cancer agents
inferred← citeshttps://doi.org/10.1021/acs.joc.2c00893openalex-snapshot
Nucleophilic Addition/Electrocyclization Strategy toward Polyheterocyclic-Fused Quinoline-2-thiones in Green Solvent
inferred← citeshttps://doi.org/10.3389/fphar.2022.993862openalex-snapshot
Perspectives of herbs and their natural compounds, and herb formulas on treating diverse diseases through regulating complicated JAK/STAT signaling
inferred← citeshttps://doi.org/10.3390/molecules28031224openalex-snapshot
Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the Horizon
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.